Clinical Trial Detail

NCT ID NCT00878254
Title Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Miami
Indications

mantle cell lymphoma

Therapies

Cyclophosphamide + Cytarabine + Doxorubicin + Etoposide + Filgrastim + Ifosfamide + Leucovorin + Mesna + Methotrexate + Rituximab + Vincristine Sulfate

Rituximab

Age Groups: senior adult

No variant requirements are available.